STAT Plus: Roche partners with Arrakis Therapeutics to develop drugs that target RNA
ARRAKIS LAB
Arrakis Therapeutics has signed on its first strategic partner: the Swiss pharma giant Roche. The companies will work to create medicines that target RNA.


No hay comentarios:
Publicar un comentario